ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993

TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes

August 29, 2014

Examples Of CCOP Cancer Control Projects Listed

May 16, 1986